Patent · US Active

Ketamine derivatives and compositions thereof

US11440874B2 · kind B2 · utility

0Cited by
4References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 12, 2020
Grant dateSep 13, 2022
Priority date
Expiry dateOct 12, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D211/62
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Ketamine derivatives and pharmaceutical compositions thereof are disclosed. When administered orally the ketamine derivatives provide increased bioavailability of ketamine in the systemic circulation. The ketamine derivatives can be used to treat neurological diseases, psychological diseases and pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.